By Shakeel Ahmed — AI Growth Lab

Boston Scientific found a cyber breach on August 25, 2026, and every manufacturing plant and distribution centre went offline for eight days. The company later cut its full-year profit outlook for the third time in 2026, blaming the lingering fallout.

This is not a story about a computer virus in an office. It is a story about hospital supplies, factory lines, and a company that could not ship while its systems were down.

What happened, in plain words

Third-quarter sales rose 1.5% to $5.138 billion, slightly ahead of expectations of about $5.05 billion.

Adjusted earnings were 73 cents a share, a penny above consensus, but below 75 cents a year earlier.

The company now expects 2026 adjusted earnings of $3.16 to $3.18 a share, down from $3.28 to $3.32, and below the $3.23 analysts had expected.

Fourth-quarter sales are projected to fall 1% to 3%, with earnings of 77 to 79 cents, below the 83 cents analysts wanted.

The disruption shaved about 300 basis points off…